Mainz Biomed N.V.Mainz Biomed N.V.Mainz Biomed N.V.

Mainz Biomed N.V.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.09 M‬EUR
‪−20.91 M‬EUR
‪863.58 K‬EUR
‪4.53 M‬
Beta (1Y)
1.47
Employees (FY)
26
Change (1Y)
−45 −63.38%
Revenue / Employee (1Y)
‪33.21 K‬EUR
Net income / Employee (1Y)
‪−804.39 K‬EUR

About Mainz Biomed N.V.


CEO
Guido Baechler
Headquarters
Mainz
Founded
2021
ISIN
NL0015000LC2
FIGI
BBG013DFGSK3
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.

Check out other big names from the same industry as 4TO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4TO is 7.76 EUR — it has decreased by −7.62% in the past 24 hours. Watch Mainz Biomed N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Mainz Biomed N.V. stocks are traded under the ticker 4TO.
4TO reached its all-time high on Jan 18, 2022 with the price of 1,054.00 EUR, and its all-time low was 6.81 EUR and was reached on Sep 24, 2024. View more price dynamics on 4TO chart.
See other stocks reaching their highest and lowest prices.
4TO stock is 22.67% volatile and has beta coefficient of 1.47. Track Mainz Biomed N.V. stock price on the chart and check out the list of the most volatile stocks — is Mainz Biomed N.V. there?
Today Mainz Biomed N.V. has the market capitalization of ‪6.09 M‬, it has increased by 32.02% over the last week.
Yes, you can track Mainz Biomed N.V. financials in yearly and quarterly reports right on TradingView.
Mainz Biomed N.V. is going to release the next earnings report on Nov 13, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 4TO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has 26 employees. See our rating of the largest employees — is Mainz Biomed N.V. on this list?
Like other stocks, 4TO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mainz Biomed N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mainz Biomed N.V. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mainz Biomed N.V. stock shows the sell signal. See more of Mainz Biomed N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.